Does Aetna Cover Depression Treatment in Delaware? A 2026 Guide

Last updated: July 23, 2026

If you have Aetna health insurance in Delaware and you or a loved one is managing depression, understanding your benefits before your first appointment can save significant time, money, and frustration. This guide walks through how Aetna may cover depression treatment in Delaware in 2026, what its pharmacy benefit manager CVS/Caremark’s formulary typically looks like for antidepressants, how Delaware’s mental health parity law protects you, and exactly how to navigate prior authorization and appeals if coverage is denied.

Ready to connect with a licensed provider?
Explore depression treatment options at Klarity Health. 2,000+ licensed providers nationwide.

Key Facts: Aetna Depression Coverage in Delaware (2026)

• PBM: CVS/Caremark (manages Aetna’s pharmacy benefits)
• DE Parity Law: Del. Code Ann. tit. 18, § 3343. Requires mental health/substance use coverage on par with medical/surgical benefits
• DE EPCS: Standard antidepressants are non-scheduled. Electronic Prescribing of Controlled Substances (EPCS) is entirely inapplicable. Spravato (esketamine) is Schedule III. EPCS required.
• Generic antidepressants: Typically Tier 1. 2 on CVS/Caremark, often no prior authorization required
• Brand/novel antidepressants: May require step therapy or PA. See formulary table below
• Spravato: Tier 4. 5, specialty PA + REMS program + treatment-resistant depression (TRD) criteria (2+ failed adequate antidepressant trials)
• Contacts: Aetna 1-800-872-3862 | CVS/Caremark 1-800-552-8159 | DE DOI 1-302-674-7300

Does Delaware Law Require Aetna to Cover Depression Treatment?

Yes. Delaware’s mental health parity statute. Del. Code Ann. tit. 18, § 3343. Aligns with the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and requires fully-insured commercial health plans to cover mental health conditions, including depression, under the same terms and limitations applied to comparable medical or surgical conditions.

In practice, § 3343 means Aetna may not:

• Apply visit limits, deductibles, or copays to depression treatment that are more restrictive than those for medical/surgical care
• Require more burdensome prior authorization or step therapy for mental health medications than for comparable medical drugs
• Impose separate higher out-of-pocket maximums for mental health services

If you believe Aetna has applied coverage limits that violate parity, you may file a complaint with the Delaware Department of Insurance (DOI) at 1-302-674-7300. Note: § 3343 applies to fully-insured Aetna plans regulated by Delaware. Self-funded employer plans (common in large companies) are governed by federal ERISA, and parity complaints go to the U.S. Department of Labor Employee Benefits Security Administration (EBSA) at 1-866-444-3272.

Aetna’s CVS/Caremark Formulary for Depression Medications (2026)

Aetna uses CVS/Caremark as its pharmacy benefit manager (PBM) in Delaware. The formulary below reflects typical CVS/Caremark tier placements and prior authorization requirements as of 2026. Actual tier and PA status may vary by specific Aetna plan. Always verify via your Aetna member portal or call 1-800-872-3862.

Delaware EPCS Requirements for Antidepressants

Delaware requires Electronic Prescribing of Controlled Substances (EPCS) for controlled medications under DE Admin Code Title 24 § 1700. For depression medications, this matters in one narrow situation:

Key takeaway: For the overwhelming majority of Delaware patients prescribed antidepressants through Klarity Health, EPCS is entirely inapplicable. These medications are not controlled substances. Spravato is the sole exception, and its in-office REMS administration requirement makes it a specialty-setting medication outside telehealth scope regardless.

Spravato (Esketamine): A Special Case

Spravato deserves specific attention because it sits at the intersection of multiple requirements:

• Schedule III controlled substance: DE EPCS required for prescribing
• FDA REMS program: May only be administered in a certified healthcare setting under supervision; the patient cannot take it home. This makes it incompatible with telehealth prescribing regardless of EPCS rules.
• CVS/Caremark PA criteria: Typically requires documented failure of 2 or more adequate antidepressant trials (treatment-resistant depression, TRD), major depressive disorder with acute suicidal ideation/behavior, or MDD with inadequate response. Depending on the specific Aetna plan.
• Prior authorization process: PA submitted by the treating clinician, typically through Aetna’s specialty pharmacy or utilization management team. Initial authorization may be for a defined course (e.g., 8 weeks induction + maintenance).

What Does Aetna Typically Cover for Depression Treatment?

Beyond prescription medications, Aetna plans in Delaware may cover a broad range of depression treatment services. Coverage specifics vary by plan design, but fully-insured Aetna plans subject to § 3343 may include:

• Initial psychiatric evaluation: Typically covered as a specialist office visit (subject to your specialist copay or coinsurance)
• Ongoing medication management visits: Covered as specialist visits; telehealth visits are generally covered on par with in-person under Delaware’s telehealth parity framework
• Psychotherapy (individual, group): Covered under behavioral health benefits; may be subject to in-network provider requirements
• Intensive outpatient programs (IOP): Typically covered; PA may be required depending on your plan
• Partial hospitalization programs (PHP): Generally covered with PA; parity protections under § 3343 apply
• Inpatient psychiatric hospitalization: Covered; PA typically required for non-emergency admissions
• Telehealth: Delaware telehealth law requires coverage for telehealth services equivalent to in-person care for most Aetna commercial plans

How to Start the Prior Authorization Process for Depression Medications

If your Aetna plan requires a PA for a brand or specialty antidepressant, here are the typical steps:

1. Your provider submits the PA request: Through Aetna’s online provider portal or by faxing a completed PA form. Include your diagnosis (ICD-10 code), the specific medication, dose, and clinical rationale.
2. Document step therapy compliance: If step therapy is required, the PA must document which prior medications were tried, for how long, and why they were inadequate (inefficacy, intolerance, contraindication).
3. Initial determination: Aetna typically issues an initial PA determination within 3 business days for non-urgent requests (72 hours) or 24 hours for urgent requests.
4. If approved: The authorization is typically valid for 12 months (maintenance prescriptions). Specialty medications like Spravato may have shorter authorization periods with renewal PA required.
5. If denied: You will receive a written denial with the specific clinical criteria not met. Proceed to the appeal process (see below).

What to Do If Aetna Denies Depression Treatment Coverage

A denial is not the end of the road. Delaware law and federal MHPAEA give you several avenues to challenge coverage decisions:

1. Internal appeal: Submit a formal written appeal to Aetna within the timeframe specified in your denial letter (typically 180 days). Include supporting clinical documentation from your provider.
2. Peer-to-peer review: Your treating provider can request a direct call with Aetna’s medical director to discuss the clinical rationale. This often resolves PA denials for medications where documentation is strong.
3. External review: If your internal appeal is denied, you may request an independent external review through the Delaware Department of Insurance at 1-302-674-7300. An independent reviewer’s decision is binding on Aetna for fully-insured plans.
4. Parity complaint: If you believe the denial reflects a mental health parity violation. E.g., Aetna applies stricter criteria to antidepressants than to comparable medical drugs. File a parity complaint with the DE DOI (fully-insured plans) or with U.S. DOL EBSA at 1-866-444-3272 (self-funded/ERISA plans).
5. CMS complaint: For ACA Marketplace Aetna plans, you may also contact CMS at 1-800-633-4227.

How to Verify Your Aetna Depression Coverage Before Your Appointment

1. Log in to your Aetna member portal at aetna.com. Navigate to Benefits > Mental Health or Behavioral Health to review your specific plan’s coverage details, copays, and deductibles for behavioral health visits.
2. Check the formulary: In your Aetna portal or at CVS/Caremark’s formulary lookup tool, search the specific antidepressant your provider is considering prescribing. Confirm the tier, any PA requirements, and quantity limits.
3. Call Aetna member services at 1-800-872-3862: Ask specifically about (a) your behavioral health deductible and out-of-pocket maximum, (b) whether your provider is in-network, (c) PA requirements for the specific medication, and (d) the step therapy requirements if applicable.
4. Call CVS/Caremark at 1-800-552-8159: Confirm the specific formulary tier and any quantity limits for the medication your provider plans to prescribe.
5. Request a benefits summary in writing: Any verbal coverage determination from Aetna can be used in an appeal if coverage is later denied.

How Klarity Health Works with Aetna Patients in Delaware

Klarity Health connects Delaware residents with 2,000+ licensed providers. Including psychiatrists, nurse practitioners, and physician assistants. Who can evaluate depression symptoms, create a personalized treatment plan, and prescribe appropriate non-controlled antidepressant medications when clinically appropriate via secure telehealth.

Our providers are experienced with CVS/Caremark’s formulary and can help navigate prior authorization by documenting step therapy history, clinical rationale, and other criteria needed for PA approval when brand or specialty medications are medically necessary.

Ready to get started?
Explore depression treatment at Klarity Health and check if your Aetna plan may cover your visit.

Frequently Asked Questions

Does Aetna cover antidepressants in Delaware?

Aetna plans in Delaware typically cover a range of antidepressants through the CVS/Caremark formulary. Generic SSRIs, SNRIs, and other first-line agents are often covered at Tier 1. 2 with no prior authorization. Brand-name and specialty antidepressants like Trintellix, Auvelity, or Spravato may require step therapy documentation or a full prior authorization. Coverage specifics vary by your individual Aetna plan. Verify via your member portal or call 1-800-872-3862.

Does Delaware’s parity law require Aetna to cover depression treatment?

Yes. Del. Code Ann. tit. 18, § 3343 requires fully-insured Aetna plans in Delaware to cover mental health conditions. Including depression. On terms no more restrictive than those applied to comparable medical or surgical benefits. This means visit limits, PA requirements, and out-of-pocket costs for depression care may not exceed those for equivalent medical care.

Do I need EPCS for my antidepressant prescription in Delaware?

For most antidepressants. SSRIs, SNRIs, bupropion, mirtazapine, TCAs, Trintellix, Auvelity. No. These are non-scheduled medications and Delaware’s EPCS requirement (DE Admin Code Title 24 § 1700) does not apply to non-controlled substances. The only antidepressant-related medication requiring EPCS in Delaware is Spravato (esketamine), which is Schedule III. Spravato also requires REMS in-office administration, making it outside the scope of telehealth regardless.

What is the prior authorization process for Trintellix or Auvelity with Aetna?

Both Trintellix (vortioxetine) and Auvelity (dextromethorphan/bupropion) are typically classified as non-preferred brand medications on CVS/Caremark formularies, requiring PA and step therapy documentation. For Trintellix, CVS/Caremark typically requires evidence of at least one prior SSRI or SNRI trial. For Auvelity, the criteria are typically more stringent. Often requiring 2 or more prior antidepressant trials. Your Klarity Health provider can submit PA requests with appropriate documentation.

Can Aetna deny coverage for depression treatment in Delaware?

Aetna may deny coverage for specific medications or services that don’t meet clinical criteria, step therapy requirements, or network limitations. However, denials can be appealed through Aetna’s internal appeals process, peer-to-peer review, and external review through the Delaware DOI (1-302-674-7300). If a denial reflects a parity violation, you may file a parity complaint with the DOI or with U.S. DOL EBSA (1-866-444-3272).

Does Aetna cover telehealth for depression in Delaware?

Most Aetna commercial plans in Delaware cover telehealth visits for behavioral health, including depression management and medication management, on terms comparable to in-person visits. Delaware has telehealth parity requirements that apply to most fully-insured commercial plans. Confirm with Aetna at 1-800-872-3862 that your specific plan covers telehealth behavioral health visits and whether your Klarity Health provider is in-network.

Disclaimer: Coverage varies by plan, employer, and plan year. The information above reflects typical Aetna and CVS/Caremark policies as of 2026 and may not reflect your specific plan’s benefits. Always verify your benefits directly with Aetna (1-800-872-3862) and CVS/Caremark (1-800-552-8159) before scheduling an appointment. This content is for informational purposes only and does not constitute legal or medical advice.

Helpful contacts:
Aetna Member Services: 1-800-872-3862
CVS/Caremark Pharmacy: 1-800-552-8159
Delaware Department of Insurance: 1-302-674-7300
U.S. DOL EBSA (ERISA/parity complaints): 1-866-444-3272
CMS (Marketplace plans): 1-800-633-4227